HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · IEX Real-Time Price · USD
18.00
-0.99 (-5.21%)
Apr 26, 2024, 2:41 PM EDT - Market open
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for HUTCHMED (China) stock have an average target of 29.7, with a low estimate of 17 and a high estimate of 50. The average target predicts an increase of 65.00% from the current stock price of 18.00.
Analyst Consensus: Buy
* Price targets were last updated on Nov 24, 2023.
Analyst Ratings
The average analyst rating for HCM stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +22.78% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | -5.56% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +177.78% | Sep 5, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +177.78% | Jul 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | -11.11% | Aug 9, 2022 |
Financial Forecast
Revenue This Year
723.50M
from 838.00M
Decreased by -13.66%
Revenue Next Year
867.05M
from 723.50M
Increased by 19.84%
EPS This Year
-0.13
from 0.60
EPS Next Year
-0.00
from -0.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 853.7M | 1.0B | 1.3B | 1.5B | 1.7B |
| Avg | 723.5M | 867.1M | 1.1B | 1.3B | 1.6B |
| Low | 624.4M | 766.4M | 907.2M | 1.1B | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.9% | 38.9% | 50.9% | 39.5% | 30.5% |
| Avg | -13.7% | 19.8% | 25.0% | 21.1% | 18.1% |
| Low | -25.5% | 5.9% | 4.6% | -0.1% | 0.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.01 | 0.08 | 0.22 |
| Avg | -0.13 | -0.00 | 0.11 |
| Low | -0.25 | -0.13 | 0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -98.4% | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.